股票简称：泰禾股份 股票代码：301665 南通泰禾化工股份有限公司 CAC Nantong Chemical Co., Ltd. （江苏省如东县洋口化学工业园区） 首次公开发行股票并在创业板上市 之 上市公告书 保荐人（主承销商） （上海市静安区新闸路 1508 号） 二〇二五年四月 南通泰禾化工股份有限公司 上市公告书 特别提示 南通泰禾化工股份有限公司（以下简称"泰禾股份"、"发行人"、"公司"、 "本公司"）股票将于 2025 年 4 月 11 日在深圳证券交易所创业板上市。 创业板公司具有业绩不稳定、经营风险高、退市风险高等特点，投资者面 临较大的市场风险。投资者应充分了解创业板市场的投资风险及本公司所披露 的风险因素，审慎做出投资决定。 本公司提醒投资者应充分了解股票市场风险及本公司披露的风险因素，在 新股上市初期切忌盲目跟风"炒新"，应当审慎决策、理性投资。 本上市公告书"报告期"指：2021 年度、2022 年度、2023 年度及 2024 年 1-6 月。 本上市公告书中若出现总数与各分项数值之和尾数不符的情况，均为四舍 五入所致。 1 南通泰禾化工股份有限公司 上市公告书 第一节 重要声明 ...

北京市天元律师事务所 关于南通泰禾化工股份有限公司 首次公开发行股票并在创业板上市的 法律意见书 北京市天元律师事务所 关于南通泰禾化工股份有限公司 首次公开发行股票并在创业板上市的 法律意见书 京天股字（2020）第 472-64 号 致：南通泰禾化工股份有限公司 根据北京市天元律师事务所（以下简称"本所"）与南通泰禾化工股份有限公 司（以下简称"发行人"或"公司"）签订的法律服务协议，本所担任公司本次首次 公开发行股票并在创业板上市的专项法律顾问，并为发行人本次发行上市出具了 京天股字（2020）第 472 号《北京市天元律师事务所关于南通泰禾化工股份有限 公司首次公开发行股票并在创业板上市的法律意见书》、京天股字（2020）第 472-1 号《北京市天元律师事务所关于南通泰禾化工股份有限公司首次公开发行 股票并在创业板上市的律师工作报告》、京天股字（2020）第 472-5 号《北京市 天元律师事务所关于南通泰禾化工股份有限公司首次公开发行股票并在创业板 上市的补充法律意见书（一）》、京天股字（2020）第 472-8 号《北京市天元律 师事务所关于南通泰禾化工股份有限公司首次公开发行股票并在创业板上市 ...

光大证券股份有限公司 关于 南通泰禾化工股份有限公司 首次公开发行股票并在创业板上市 之 上市保荐书 保荐机构 二〇二五年四月 南通泰禾化工股份有限公司 上市保荐书 深圳证券交易所： 南通泰禾化工股份有限公司（以下简称"南通泰禾"、"发行人"、"公 司"）申请首次公开发行股票并在创业板上市，发行人本次发行股票总数为 4,500 万股，全部为公开发行新股。光大证券股份有限公司（以下简称"光大证券"、 "保荐机构"、"本保荐机构"）认为发行人申请首次公开发行股票并在创业板 上市完全符合《中华人民共和国公司法》（以下简称"《公司法》"）、《中华 人民共和国证券法》（以下简称"《证券法》"）、《首次公开发行股票注册管 理办法》（以下简称"《首发注册管理办法》"）、《深圳证券交易所创业板股 票上市规则》的有关规定，特推荐其股票在贵所创业板上市交易。 如无特别说明，本上市保荐书中的简称或名词的释义与《南通泰禾化工股份 有限公司首次公开发行股票并在创业板上市招股说明书》中相同。 1 南通泰禾化工股份有限公司 上市保荐书 保荐机构及保荐代表人声明 光大证券股份有限公司及具体负责本次证券发行项目的保荐代表人杜攀明、 刘铁波已根 ...

Core Viewpoint - Taihe Co., Ltd. is set to go public with an issuance price of 10.27 yuan per share, focusing on the research, production, and sales of pesticide products and functional chemicals [1] Group 1: Business Overview - Taihe Co., Ltd. specializes in the development, production, and sales of pesticide products and functional chemicals, emphasizing the principle of maintaining a continuous technological advantage in its products [1] - The company's core products include significant market leaders such as the fungicide pyraclostrobin, the herbicide 2,4-D, and the protective fungicide chlorothalonil, with pyraclostrobin being the world's largest fungicide and 2,4-D being the largest herbicide of its kind [1] - Taihe has established long-term strategic partnerships with multinational companies like Syngenta, Dow, and Honeywell, with exports covering major markets in South America, North America, Southeast Asia, and Europe [1] Group 2: Financial Performance - From 2021 to the first half of 2024, Taihe's operating revenues were 3.579 billion yuan, 5.099 billion yuan, 3.868 billion yuan, and 1.959 billion yuan, while net profits attributable to the parent company were 398 million yuan, 649 million yuan, 346 million yuan, and 106 million yuan respectively [2] - Research and development expenditures during the same period were 121 million yuan, 181 million yuan, 149 million yuan, and 61.016 million yuan [2] Group 3: Strategic Initiatives - The company aims to enhance the production capacity of its key product, pyraclostrobin, and scale up the production of newly developed pesticide raw materials, while also establishing a research and development center [3] - These initiatives are expected to diversify the product range, optimize product structure, and strengthen innovation in products and technology, thereby consolidating and enhancing the company's market position and overall competitiveness [3]

Core Viewpoint - 泰禾股份 is initiating its IPO with a share price of 10.27 yuan and a PE ratio of 13.4 times, focusing on the research, production, and sales of pesticide products and functional chemicals [1] Company Overview - 泰禾股份 specializes in the development, production, and sales of pesticide products and functional chemicals, holding a leading position in key products such as 百菌清, 嘧菌酯, and 2,4-D [1] - The company leverages its proprietary technology and extensive manufacturing management experience to serve global customers, establishing itself as a group manufacturing enterprise with industry-leading capabilities [1] Financial Performance - The company reported revenues of approximately 35.79 billion yuan, 50.99 billion yuan, 38.68 billion yuan, and 19.59 billion yuan for the years 2021, 2022, 2023, and the first half of 2024, respectively [2] - Net profits for the same periods were approximately 4.31 billion yuan, 6.62 billion yuan, 3.38 billion yuan, and 1.1 billion yuan [2] Asset and Liability Metrics - As of June 30, 2024, total assets amounted to 51,014.19 million yuan, with equity attributable to shareholders at 28,608.27 million yuan [3] - The company's asset-liability ratio for the parent company was 23.86% and for the consolidated entity was 35.72% [3] Strategic Partnerships - 泰禾股份 has established long-term strategic partnerships with multinational companies such as Syngenta, Dow, and Honeywell, enhancing its market presence in regions including South America, North America, Southeast Asia, and Europe [2]